Invention Grant
- Patent Title: Chiral aziridine phosphoramidate compounds
-
Application No.: US15480268Application Date: 2017-04-05
-
Publication No.: US10087202B2Publication Date: 2018-10-02
- Inventor: Harold Meckler , Brian Gregg , Jie Yang
- Applicant: CHEMAPOTHECA, LLC
- Applicant Address: US NY Delmar
- Assignee: CHEMAPOTHECA, LLC
- Current Assignee: CHEMAPOTHECA, LLC
- Current Assignee Address: US NY Delmar
- Agency: Juneau & Mitchell
- Agent Todd L. Juneau
- Main IPC: C07F9/564
- IPC: C07F9/564

Abstract:
The invention includes processes for the synthesis of amphetamine, dexamphetamine, methamphetamine, derivatives of these, including their salts, and novel precursors and intermediates obtained thereby, by synthesizing aziridine phosphoramidate compounds in specified solvents at specified temperatures, and then converting to a novel aryl or aryl-alkyl phosphoramidate precursors using an organometallic compound such as a copper salt, where the novel aryl or aryl-alkyl phosphoramidate precursor is then easily converted to the target compounds using known reactions.
Public/Granted literature
- US20170210768A1 Novel Chiral Aziridine Phosphoramidate Compounds Public/Granted day:2017-07-27
Information query